Mandate

Vinge acted as Swedish legal advisor to Viking Global Investors in connection with its agreement to acquire a significant controlling stake in Voyado, a customer experience platform tailored for the retail sector, in a transaction that values the company at SEK 3,5 billion

Voyado has established itself as one of the fastest-growing and most trusted retail technology providers in the Nordics. Its platform is deeply embedded in many retailers’ mission-critical infrastructure, helping retailers and brands turn customer and product data into loyalty, optimize e-commerce performance, and personalize the shopping experience - in-store and online.

Viking will partner with Voyado’s founders and existing institutional investors including NovAx, Verdane, H&M and eEquity, all of whom will remain as shareholders in the company.

The transaction is subject to customary regulatory approvals.

Vinge’s team consisted mainly of Christina Kokko, Matthias Pannier, Edvard Gustafsson, Alex Forsberg and Ellenor Eckerborn (M&A), Victor Ericsson (Tax), Mathilda Persson, Nicklas Thorgerzon, Elis Allmark and Siri Blomberg (Commercial Agreements, IT and GDPR), Nour Makie and Ida Appelgren (Banking and Finance), Hayaat Ibrahim and Gulestan Ali (Compliance), Simon Söderholm and Agnes Pigg (Employment), Arvid Axelryd, Alva Skott and Maja Helm (IP), Madelene Andersson and Wilma Hellman (Real Estate and Environment), Daniel Wendelsson and Hampus Peterson (FDI), Julia Ulander Kull (Transaction Support Coordinator).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025